STAT3 is Activated by CTGF-mediated Tumor-stroma Cross Talk to Promote HCC Progression-Reference-Cited by-同舟云学术

STAT3 is Activated by CTGF-mediated Tumor-stroma Cross Talk to Promote HCC Progression

Published:2023 Issue:1 Volume:15 Page:99-119
ISSN:2352-345X
Container-title:Cellular and Molecular Gastroenterology and Hepatology
language:en
Short-container-title:Cellular and Molecular Gastroenterology and Hepatology

Author:

Makino Yuki,Hikita Hayato,Kato Seiya,Sugiyama Masaya,Shigekawa Minoru,Sakamoto Tatsuya,Sasaki Yoichi,Murai Kazuhiro,Sakane Sadatsugu,Kodama Takahiro,Sakamori Ryotaro,Kobayashi Shogo,Eguchi Hidetoshi,Takemura Nobuyuki,Kokudo Norihiro,Yokoi Hideki,Mukoyama Masashi,Tatsumi Tomohide,Takehara Tetsuo^ORCID

Funder

Ministry of Education, Culture, Sports, Science and Technology

Japan Agency for Medical Research and Development

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference37 articles.

1. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6;Zhong;Science,1994

2. Therapeutically exploiting STAT3 activity in cancer - using tissue repair as a road map;Huynh;Nat Rev Cancer,2019

3. Stat3 as an oncogene;Bromberg;Cell,1999

4. STAT3 target genes relevant to human cancers;Carpenter;Cancers (Basel),2014

5. A global view of hepatocellular carcinoma: trends, risk, prevention and management;Yang;Nat Rev Gastroenterol Hepatol,2019

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Blocking the MIR155HG/miR-155 axis reduces CTGF-induced inflammatory cytokine production and α-SMA expression via upregulating AZGP1 in hypertrophic scar fibroblasts;Cellular Signalling;2024-08

2. Integrating Network Pharmacology and Experimental Validation to Decipher the Mechanism of Action of Astragalus–Atractylodes Herb Pair in Treating Hepatocellular Carcinoma;Drug Design, Development and Therapy;2024-06

3. Effect of curcumin nanoparticles on proliferation and migration of mouse airway smooth muscle cells and airway inflammatory infiltration;Frontiers in Pharmacology;2024-04-19

4. Interleukin-6 in Hepatocellular Carcinoma: A Dualistic Point of View;Biomedicines;2023-09-24

5. STAT3 as a newly emerging target in colorectal cancer therapy: Tumorigenesis, therapy response, and pharmacological/nanoplatform strategies;Environmental Research;2023-09